Jesse Lee Berry, MD

Jesse L. Berry, MD is Professor Ophthalmology, Director of Ocular Oncology and Chief of Ophthalmology at Children’s Hospital Los Angeles (CHLA) and the University of Southern California (USC) Roski Eye Institute. She received her undergraduate and medical degree from Harvard University followed by ophthalmology and fellowship training at CHLA+USC under the mentorship of A. Linn Murphree, MD. Dr. Berry is the founder of Women in Ocular Oncology, President of the International Society of Ocular Oncology (ISOO, 2024-26) and treasurer of the American Association for Ophthalmic Oncology and Pathology (AAOOP, 2023-2025). Her clinical expertise focuses on retinoblastoma and uveal melanoma. She holds the A. Linn Murphree, MD Chair in Retinoblastoma and the Berle and Lucy Adams Chair in Cancer Research. She has pioneered development of the aqueous humor as a liquid biopsy for retinoblastoma and other ocular tumors; this research is supported by the National Cancer Institute.

• 2000
   -: Harvard College Scholarship: Elizabeth Cary Agassiz Scholar, 2000
   – 2004
• 2000
   -: Malcolm Kinsberg Scholarship, 2000
   – 2004
• Kappa Alpha Theta Foundation Scholarship, 2002
• David Rockefeller Center of Latin American Studies Grant, 2003
• 2004
   -: Nevil & Louise Ford Scholarship Fund, 2004
   – 2008
• Harvard Medical International Initiatives in Research Grant, 2005
• Center for Eye Research and Education McCleary Grant, 2007
• Doheny Eye Institute Medical Knowledge Award, 2011
• Starr Schulman Fellowship, 2012
• Department of Health Services Innovation Grant, 2012
• Society of Heed Fellows, 2013
• 2013
   -: University of Southern California Excellence in Resident Teaching Award, 2013
   – 2014

• Harvard University — BA — 2004
• Harvard Medical School — MD — 2008
• USC Roski Eye Institute — Ophthalmology Residency — 2012
• Children's Hospital Los Angeles — Ocular Oncology Fellowship — 2014

• Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.
  NIH · R01CA282759 · Aug 1, 2023 – Jul 31, 2028 · Role: Principal Investigator
• Development of a surrogate liquid biopsy from the aqueous humor in retinoblastoma eyes.
  NIH · K08CA232344 · Aug 1, 2018 – Jul 31, 2023 · Role: Principal Investigator

• Cobrinik, David
• Jubran, Rima
• Xu, Liya
• Belson, Paula
• Nagiel, Aaron
• Shah, Rachana